GlaxoSmithKline
Do more, feel better, live longer
GSK in focus
Cystic fibrosis:
the vicious cycle
Cystic fibrosis (CF) is caused
by a mutation
in a gene called
the cystic fibrosis transmembrane
conductance regulator.
That's the science - but the reality
for patients with this life-threatening
disease can be hard.
What is GSK
doing to help them?
Corporate press releases
[an error occurred while processing this directive] [an error occurred while processing this directive]19 September 2008
GSK update on FDA review of Promacta® (eltrombopag)
16 September 2008
New data for GlaxoSmithKline’s pre-pandemic H5N1 influenza vaccine, Prepandrix™, show administration flexibility for pandemic planning
16 September 2008
GSK and Xenoport announce submission of new drug application requesting FDA approval of Solzira™ for Restless Legs Syndrome
Investors
LSE
995p
-88.00
12 Oct 2008 closed
NYSE
35.55
+0.14
12 Oct 2008 closed
Hemscott Group Limited
- Share price charting tool
- Information for shareholders
- Annual Report and Review 2007
- Product pipeline
